[et_pb_section fb_built=”1″ _builder_version=”3.22″ custom_margin=”||-90px|||”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.3.2″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” link_option_url_new_window=”on”]
New York, New York, March 23, 2020 – Concertio, the leading provider of AI-powered performance optimization software, announced today that it will grant free access to Concertio’s optimization tools throughout 2020 to accredited research institutions and private entities as they race to find and scale appropriate diagnostics and drugs for COVID-19.
“As this global health emergency unfolds, the need for better diagnostics, which consist of rapid, accurate detection and testing of COVID-19, becomes ever so urgent”, said Dr. Tomer Morad, Co-Founder and CEO of Concertio. “Speed is key in this crisis, and Concertio will contribute its part to accelerate the computations required for the development of diagnostics and drugs for COVID-19.”
Concertio’s patented Optimizer products boost the performance of scientific calculations in applications such as GROMACS by optimizing the full application stack of the clusters, including the BIOS, network, processor, firmware, OS, middleware, applications and the compiler flags. To gain access please email Concertio at [email protected].